Daratumumab/Pom/Dex Salvage Beneficial in R/R MM Single Institution Retrospective Analysis

Laurie Cohen, MD, on when and how to retest for GH deficiency, how soon to start GH replacement in cancer survivors from Clinical Care Options (CCO)

Laurie E. Cohen, MD Released: April 22, 2021

Danielle Friedman, MD, on adipose dysfunction, insulinopenia, obesity, and diabetes after irradiation in cancer survivors

Danielle N. Friedman, MD, MS Released: April 22, 2021

On-demand Clinical Care Options (CCO) webcast with experts’ review of data informing optimal management of relapsed/refractory myeloma

Shaji K. Kumar, MD
Program Director Suzanne Lentzsch, MD, PhD Saad Z. Usmani, MD, MBA, FACP Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Released: March 31, 2021 Expired: March 30, 2022

From Clinical Care Options (CCO), read an expert commentary on how to safely provide CAR T-cell therapy during the COVID-19 pandemic

Caron A. Jacobson, MD Released: March 31, 2021